YJL195C Antibody

What is YJL195C protein and why is it studied in research?

YJL195C is a putative uncharacterized protein found in Saccharomyces cerevisiae (baker's yeast, strain 204508/S288c). It is classified as a potential multi-pass membrane protein with a molecular weight of approximately 25,439 Da. The gene is considered a "dubious gene prediction" as it partially overlaps with CDC6, which is a critical regulator of DNA replication . Researchers study this protein to better understand yeast membrane biology and potentially clarify its functional relationship with overlapping genes in the yeast genome.

What are the key specifications of commercially available YJL195C antibodies?

The primary YJL195C antibodies used in research are polyclonal antibodies raised in rabbits against recombinant Saccharomyces cerevisiae YJL195C protein. These antibodies are typically supplied in liquid form with preservatives (e.g., 0.03% Proclin 300) and stabilizers (e.g., 50% Glycerol in 0.01M PBS, pH 7.4). The antibodies are non-conjugated and unmodified, making them suitable for various detection methods . The antibody's specificity is for the S. cerevisiae strain 204508/S288c variant of the protein.

What experimental applications are YJL195C antibodies validated for?

YJL195C antibodies are primarily validated for ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot applications. These methods allow researchers to detect and quantify the presence of YJL195C protein in yeast cell extracts or purified samples . When using these antibodies, it's essential to include appropriate controls to ensure specificity, particularly given the "dubious" gene prediction status of YJL195C.

What is the optimal protocol for using YJL195C antibody in Western Blot analyses?

For Western Blot analysis with YJL195C antibody, researchers should:

• Prepare yeast cell lysates under conditions that preserve membrane proteins (use of detergents like Triton X-100 or CHAPS)

• Separate proteins using SDS-PAGE (10-12% gel recommended for the 25kDa target)

• Transfer proteins to PVDF or nitrocellulose membrane

• Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Incubate with primary YJL195C antibody (typically at 1:500-1:2000 dilution) overnight at 4°C

• Wash membranes 3-5 times with TBST

• Incubate with appropriate HRP-conjugated secondary antibody

• Develop using chemiluminescent substrate

For optimal results, researchers should perform a titration experiment to determine the ideal antibody concentration for their specific sample .

How can researchers optimize YJL195C antibody usage in ELISA?

To optimize YJL195C antibody performance in ELISA:

• Coat plates with purified recombinant YJL195C protein or yeast cell extract (typically 1-10 μg/ml in carbonate buffer pH 9.6)

• Block with 1-5% BSA in PBS-T for 1-2 hours at room temperature

• Add serial dilutions of the YJL195C antibody (starting from 1:100 to 1:10,000) to determine optimal concentration

• Incubate for 1-2 hours at room temperature or overnight at 4°C

• Wash thoroughly with PBS-T (at least 4-5 washes)

• Add HRP-conjugated secondary antibody

• Develop with appropriate substrate and measure absorbance

Researchers should consider testing different blocking agents and incubation times to minimize background and maximize signal-to-noise ratio .

What sample preparation methods are most effective when working with YJL195C as a membrane protein?

Since YJL195C is a putative multi-pass membrane protein, optimal sample preparation involves:

• Cell lysis using methods that preserve membrane protein integrity:

  • Mechanical disruption (glass beads for yeast)

  • Enzymatic treatment (zymolyase for yeast cell walls)

  • Gentle detergent extraction

• Membrane protein solubilization with appropriate detergents:

  • Non-ionic detergents (Triton X-100, NP-40, or Digitonin at 0.5-1%)

  • Zwitterionic detergents (CHAPS or DDM at 0.1-0.5%)

• Buffer optimization:

  • pH 7.2-7.5

  • 150-300 mM NaCl

  • Protease inhibitor cocktail

  • 5-10% glycerol as stabilizer

This approach maximizes protein extraction while maintaining native conformation for antibody recognition .

Can yeast-based systems be used to generate antibodies against YJL195C instead of animal immunization?

Yes, yeast-based systems offer an alternative to traditional animal immunization for generating antibodies against YJL195C. This approach uses engineered yeast cells displaying a library of antibody fragments on their surface. The method involves:

• Creating a diverse library of antibody fragments (typically nanobodies) expressed on yeast cell surfaces

• Labeling purified YJL195C protein with a fluorescent molecule

• Incubating the labeled protein with the yeast library

• Using fluorescence-activated cell sorting (FACS) to isolate yeast cells displaying antibody fragments that bind to YJL195C

• Sequencing the DNA of positive clones to identify the binding antibody sequences

• Expressing the identified antibodies in E. coli or other systems for scale-up

This method offers several advantages: it takes only 3-6 weeks (compared to 3-6 months for animal immunization), has a higher success rate, and avoids animal use. The technique has been successfully applied to various membrane proteins and could be adapted for generating antibodies against YJL195C .

What are the technical considerations when implementing a yeast display system for antibody generation against yeast proteins like YJL195C?

When developing a yeast display system to generate antibodies against yeast proteins like YJL195C, researchers should consider:

• Cross-reactivity concerns:

  • Using different yeast strains for display and target protein

  • Implementing negative selection steps to remove clones that bind to common yeast epitopes

• Library design strategies:

  • Starting with synthetic or naive camelid antibody libraries (~500 million variants)

  • Ensuring adequate library diversity to cover potential binding epitopes

• Selection optimization:

  • Multiple rounds of selection with increasing stringency

  • Alternating positive and negative selection

  • Using detergent-solubilized protein to maintain membrane protein conformation

• Validation requirements:

  • Testing antibody specificity against wild-type and YJL195C knockout strains

  • Confirming binding via multiple methods (ELISA, Western blot, immunoprecipitation)

This approach typically requires specialized equipment for FACS and expertise in library generation but offers advantages in terms of speed and specificity for difficult targets like membrane proteins .

How can researchers address potential cross-reactivity with CDC6 when using YJL195C antibodies?

Since YJL195C partially overlaps with CDC6, addressing potential cross-reactivity requires careful experimental design:

• Epitope mapping:

  • Determine which regions of YJL195C the antibody recognizes

  • Compare these regions with CDC6 sequence to identify potential cross-reactive epitopes

• Validation strategies:

  • Test antibody against purified CDC6 protein

  • Perform immunoprecipitation followed by mass spectrometry

  • Use YJL195C knockout strains as negative controls

• Absorption techniques:

  • Pre-absorb antibody with purified CDC6 to remove cross-reactive antibodies

  • Use peptide competition assays with specific peptides from non-overlapping regions

• Data interpretation approaches:

  • Always include appropriate controls when interpreting results

  • Consider dual labeling with CDC6-specific antibodies to distinguish signals

  • Verify key findings with alternative detection methods

These methodologies help ensure that observed signals genuinely represent YJL195C rather than CDC6 or other cross-reactive proteins .

What strategies can improve detection sensitivity for low-abundance YJL195C protein?

For improving detection of low-abundance YJL195C protein, researchers can implement:

• Signal amplification techniques:

  • Tyramide signal amplification (TSA) for immunohistochemistry

  • Enhanced chemiluminescence (ECL) substrates for Western blot

  • Biotin-streptavidin amplification systems

• Sample enrichment methods:

  • Subcellular fractionation to concentrate membrane proteins

  • Immunoprecipitation before detection

  • Ultracentrifugation to isolate membrane fractions

• Optimized detection protocols:

  • Extended antibody incubation times (overnight at 4°C)

  • Increased antibody concentration (carefully titrated)

  • Reduced washing stringency (balanced against background)

• Specialized imaging:

  • Cooled CCD cameras for Western blot detection

  • Long exposure times with low background substrates

  • Digital stacking of multiple exposures

These approaches can significantly improve the signal-to-noise ratio, allowing detection of even low-abundance YJL195C protein in complex samples .

How can deep learning models like DyAb improve YJL195C antibody design and affinity?

Deep learning models such as DyAb can revolutionize YJL195C antibody design through:

• Affinity prediction and optimization:

  • Predicting binding affinity changes (ΔpKD) for antibody variants

  • Identifying optimal combinations of mutations to enhance binding properties

  • Achieving correlation coefficients of r=0.84 between predicted and measured affinities

• Rational design implementation:

  • Starting with known antibody sequences

  • Generating combinations of affinity-improving mutations at specific edit distances

  • Using genetic algorithms to iteratively improve antibody properties

• Expression probability assessment:

  • Evaluating the likelihood of successful expression for designed variants

  • Achieving expression rates of >85% for computationally designed antibodies

  • Avoiding designs that may fold incorrectly

• Practical application workflow:

  • Begin with ~100 variants of an initial YJL195C antibody

  • Use the DyAb model to predict improvements in binding affinity

  • Generate and test top-scoring designs

  • Incorporate new data to refine the model iteratively

This computational approach can significantly accelerate YJL195C antibody optimization while maintaining high expression rates and improving binding properties, potentially reducing development time from months to weeks .

What complementary determining region (CDR) mutation strategies are most effective for optimizing YJL195C antibody binding?

Based on computational and experimental data, effective CDR mutation strategies for optimizing YJL195C antibody binding include:

• Targeted CDR scanning approach:

  • Perform alanine scanning of all CDR residues except cysteine

  • Identify positions where mutations improve binding affinity

  • Focus on heavy chain CDR residues for greatest impact

• Combinatorial design principles:

  • Combine individual beneficial mutations (typically 3-4) into new variants

  • Avoid high edit distances (>8) that may compromise expressibility

  • Balance charged and hydrophobic residue changes

• Character-based mutation strategy:

  Mutation Type	Expected Effect	Recommended CDRs
  Aliphatic	Enhanced hydrophobic interactions	CDR3
  Polar	Improved hydrogen bonding	CDR1, CDR2
  Charged	Electrostatic interactions	CDR1, CDR2, CDR3

• Iterative refinement process:

  • Test initial combinatorial designs

  • Incorporate successful variants into training data

  • Generate second-round designs with improved predicted properties

  • Achieve affinity improvements of 3-50 fold through iterative optimization

This systematic approach to CDR engineering can produce YJL195C antibodies with substantially improved binding characteristics while maintaining high expression levels .

What quality control measures should be implemented when working with YJL195C antibodies?

Comprehensive quality control for YJL195C antibodies should include:

• Specificity validation:

  • Western blot against yeast lysates (wild-type vs. YJL195C knockout)

  • Peptide competition assays

  • Cross-reactivity testing against related yeast proteins

• Functional performance assessment:

  • Titration curves to determine optimal working concentration

  • Batch-to-batch consistency testing

  • Stability testing under various storage conditions

• Documentation requirements:

  • Detailed records of validation experiments

  • Standard curves and positive controls

  • Lot-specific performance metrics

• Storage and handling protocols:

  • Aliquoting to avoid freeze-thaw cycles

  • Brief centrifugation if solution becomes entrapped in vial cap

  • Adherence to recommended storage temperature (-20°C or -80°C)

Implementing these quality control measures ensures reliable and reproducible results when working with YJL195C antibodies in research applications .

How can researchers troubleshoot non-specific binding issues with YJL195C antibodies?

To address non-specific binding with YJL195C antibodies, researchers can implement:

• Blocking optimization:

  • Test different blocking agents (BSA, non-fat milk, commercial blockers)

  • Increase blocking time and concentration

  • Add 0.1-0.5% Tween-20 to reduce hydrophobic interactions

• Antibody incubation adjustments:

  • Reduce antibody concentration

  • Add 0.1-0.5% Triton X-100 to reduce background

  • Include 5% normal serum from the secondary antibody species

• Washing protocol enhancement:

  • Increase number of washes (5-6 times)

  • Use higher salt concentration in wash buffers (up to 500mM NaCl)

  • Add 0.1% SDS to wash buffers for Western blots

• Pre-absorption techniques:

  • Pre-incubate antibody with cell lysate from YJL195C knockout yeast

  • Use a peptide competition assay to confirm specific binding

  • Immunodeplete cross-reactive antibodies using related proteins

These approaches systematically address the common causes of non-specific binding, improving signal-to-noise ratio and data reliability .

How might novel antibody formats enhance YJL195C research beyond traditional polyclonal antibodies?

Novel antibody formats offer significant advantages for YJL195C research:

• Single-domain antibodies (nanobodies):

  • Smaller size (~15 kDa) enables access to cryptic epitopes on membrane proteins

  • Greater stability in detergent environments used for membrane protein research

  • Potential for intracellular expression as functional inhibitors

• Bispecific antibodies:

  • Simultaneous targeting of YJL195C and interacting proteins

  • Enhanced co-localization studies

  • Potential for protein complex isolation through dual epitope recognition

• Site-specific conjugated antibodies:

  • Precisely positioned fluorophores or enzymes

  • Improved orientation in biosensor applications

  • Reduced impact on antigen binding

• Recombinant antibody fragments:

  • Fab and scFv formats with reduced background

  • Engineered variants with enhanced stability

  • Expression in microbial systems without glycosylation heterogeneity

These next-generation formats could overcome limitations of traditional polyclonal antibodies, particularly for challenging membrane proteins like YJL195C, enabling new experimental approaches and applications .

What emerging technologies might enhance our understanding of YJL195C function using antibody-based approaches?

Emerging technologies poised to advance YJL195C research include:

• Proximity labeling techniques:

  • Antibody-APEX2 fusions for identifying proximal proteins

  • BioID approaches to map protein interaction networks

  • Split-enzyme complementation to detect specific interactions

• Super-resolution microscopy applications:

  • STORM/PALM imaging with specialized antibody conjugates

  • Expansion microscopy for enhanced visualization of membrane structures

  • Correlative light and electron microscopy for ultrastructural localization

• Antibody-directed protein degradation:

  • PROTAC-antibody conjugates for targeted degradation

  • Nanobody-based degrons for functional studies

  • Conditionally stable antibody fragments for temporal control

• Single-cell antibody-based proteomics:

  • Antibody barcoding for multiplex detection

  • Mass cytometry with metal-labeled antibodies

  • Spatial transcriptomics combined with antibody detection

These technologies leverage antibodies as highly specific molecular tools to advance beyond simple detection, enabling functional studies and systems-level analysis of YJL195C and its biological context .